Effects of C-Reactive Protein and Cholesterol on Responsiveness In Vitro of the Internal Thoracic Artery to Angiotensin II in Patients Having Coronary Artery Bypass Grafting

American Journal of Cardiology

Volumn 98, Issue 6, 2006, Pages 751-753

  van der Harst, Pim ^a   Asselbergs, Folkert W ^a   Buikema, Hendrik ^a   Voors, Adriaan A ^a   van Veldhuisen, Dirk J ^a   van Gilst, Wiek H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; C REACTIVE PROTEIN; CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; INTERNAL MAMMARY ARTERY; MALE; PATHOGENESIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

ANGINA PECTORIS; ANGIOTENSIN II; C-REACTIVE PROTEIN; CHOLESTEROL; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MAMMARY ARTERIES; MIDDLE AGED; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33748089330     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.04.010     Document Type: Article

References (17)

1. Wagenaar L.J., Voors A.A., Buikema H., and van Gilst W.H. Angiotensin receptors in the cardiovascular system. Can J Cardiol 18 (2002) 1331-1339
2. Li D., Saldeen T., Romeo F., and Mehta J.L. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation 102 (2000) 1970-1976
3. Nickenig G., Sachinidis A., Michaelsen F., Bohm M., Seewald S., and Vetter H. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation 95 (1997) 473-478
4. van der Harst P., Wagenaar L.J., Buikema H., Voors A.A., Plokker H.W., Morshuis W.J., Six A.J., Boonstra P.W., Nickenig G., Wassmann S., et al. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease. Am J Cardiol 96 (2005) 1361-1364
5. Wang C.H., Li S.H., Weisel R.D., Fedak P.W., Dumont A.S., Szmitko P., Li R.K., Mickle D.A., and Verma S. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107 (2003) 1783-1790
6. van der Harst P., Volbeda M., Voors A.A., Buikema H., Wassmann S., Bohm M., Nickenig G., and van Gilst W.H. Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting. Hypertension 44 (2004) 930-934
7. Lloyd-Jones D.M., Wilson P.W., Larson M.G., Leip E., Beiser A., D'Agostino R.B., Cleeman J.I., and Levy D. Lifetime risk of coronary heart disease by cholesterol levels at selected ages. Arch Intern Med 163 (2003) 1966-1972
8. Nickenig G., Baumer A.T., Temur Y., Kebben D., Jockenhovel F., and Bohm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 100 (1999) 2131-2134
9. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
10. Haverkate F., Thompson S.G., Pyke S.D.M., Gallimore J.R., Pepys M.B., Concerted Action on Thrombosis, and Disabilities Angina Pectoris Study Group E. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349 (1997) 462-466
11. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
12. Jialal I., Devaraj S., and Venugopal S.K. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension 44 (2004) 6-11
13. Hattori Y., Matsumura M., and Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 58 (2003) 186-195
14. Pasceri V., Cheng J.S., Willerson J.T., Yeh E.T., and Chang J. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103 (2001) 2531-2534
15. Pasceri V., Patti G., Nusca A., Pristipino C., Richichi G., and Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 110 (2004) 674-678
16. Zwaka T.P., Hombach V., and Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103 (2001) 1194-1197
17. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565